Literature DB >> 6995419

Prevention of emergence of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim.

R N Grüneberg, A M Emmerson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6995419     DOI： 10.1093/jac/6.3.349

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.

Authors:  G E Stein; D Gurwith; M Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

2.  Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.

Authors:  R N Grüneberg; A M Emmerson
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.